DIGITAL ORGANIZING POWER-BUILDING AND ENGAGEMENT LABS
OAKLAND, CA
What changed
NIH U54 · $0.3M · Project 1
7w agoGrant renewalMay 25, 2026Source filing (opens the source filing in a new tab)
Momentum
Momentum 94 out of 100, unchanged since the last recompute.
Accelerating: several high-weight events landed recently.
Runway (estimate)
No disclosed raise on file, so there is nothing to model from.
Stage
Grant-only
The furthest-along thing in the public record. Not a projection.
Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.
Peer position
12,707 pre-ticker oncology companies at Grant-only
Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.
Compare seatsA ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.
Grant to raise
Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.
- Grant
R01 · $539k · non-dilutive
Sep 20, 2024DIGITAL ORGANIZING POWER-BUILDING AND ENGAGEMENT LABS · PI AKOM, ANTWI AARON · NIMHD · award ends May 31, 2028 · The Black Zones: Harnessing Tech Enabled Community Driven Data, Big Population Health Data, & Agent-Based Models to Transform the Measures & Metrics around Longevity
NIH RePORTER · NIH RePORTER 11193990 (opens the source filing in a new tab)
- Grant
R01 · $730k · non-dilutive
Sep 1, 2024UNIVERSITY OF CALIFORNIA AT DAVIS · PI FEJERMAN, LAURA · NCI · award ends Aug 31, 2029 · Latin America Genomics of Breast Cancer Risk Study (LAGENO-BCR)
NIH RePORTER · NIH RePORTER 11179412 (opens the source filing in a new tab)
- Grant
U54 · $93k · non-dilutive
Jun 26, 2023STANFORD UNIVERSITY · PI REHKOPF, DAVID H · NCI · award ends Apr 30, 2028 · The Upstream Center: Income Interventions to Address the Fundamental Causes of Cancer
NIH RePORTER · NIH RePORTER 11212121 (opens the source filing in a new tab)
- Grant
U54 · $338k · non-dilutive
Jun 26, 2023STANFORD UNIVERSITY · PI REHKOPF, DAVID H · NCI · award ends Apr 30, 2028 · Career Enhancement Core
NIH RePORTER · NIH RePORTER 11078844 (opens the source filing in a new tab)
- Grant
U54 · $338k · non-dilutive
Jun 26, 2023STANFORD UNIVERSITY · PI BONDY, MELISSA L. · NCI · award ends Apr 30, 2028 · Administrative Core
NIH RePORTER · NIH RePORTER 11078833 (opens the source filing in a new tab)
- Grant
U54 · $2.0M · non-dilutive
Jun 26, 2023STANFORD UNIVERSITY · PI REHKOPF, DAVID H · NCI · award ends Apr 30, 2028 · The Upstream Center: Income Interventions to Address the Fundamental Causes of Cancer
NIH RePORTER · NIH RePORTER 11078832 (opens the source filing in a new tab)
- Grant
U54 · $388k · non-dilutive
Jun 26, 2023STANFORD UNIVERSITY · PI REHKOPF, DAVID H · NCI · award ends Apr 30, 2028 · Research and Methods Core
NIH RePORTER · NIH RePORTER 11078835 (opens the source filing in a new tab)
- Grant
U54 · $338k · non-dilutive
Jun 26, 2023STANFORD UNIVERSITY · PI GRUSKY, DAVID B · NCI · award ends Apr 30, 2028 · Project 1
NIH RePORTER · NIH RePORTER 11078838 (opens the source filing in a new tab)
- Grant
U54 · $338k · non-dilutive
Jun 26, 2023STANFORD UNIVERSITY · PI REHKOPF, DAVID H · NCI · award ends Apr 30, 2028 · Project 2
NIH RePORTER · NIH RePORTER 11078841 (opens the source filing in a new tab)
- Grant
U54 · $253k · non-dilutive
Jun 26, 2023STANFORD UNIVERSITY · PI GRUSKY, DAVID B · NCI · award ends Apr 30, 2028 · Project 1
NIH RePORTER · NIH RePORTER 11417148 (opens the source filing in a new tab)
- Grant
U54 · $296k · non-dilutive
Jun 26, 2023STANFORD UNIVERSITY · PI REHKOPF, DAVID H · NCI · award ends Apr 30, 2028 · Career Enhancement Core
NIH RePORTER · NIH RePORTER 11417157 (opens the source filing in a new tab)
- Grant
U54 · $295k · non-dilutive
Jun 26, 2023STANFORD UNIVERSITY · PI REHKOPF, DAVID H · NCI · award ends Apr 30, 2028 · Project 2
NIH RePORTER · NIH RePORTER 11417154 (opens the source filing in a new tab)
- Grant
U54 · $398k · non-dilutive
Jun 26, 2023STANFORD UNIVERSITY · PI BONDY, MELISSA L. · NCI · award ends Apr 30, 2028 · Administrative Core
NIH RePORTER · NIH RePORTER 11417140 (opens the source filing in a new tab)
- Grant
U54 · $1.9M · non-dilutive
Jun 26, 2023STANFORD UNIVERSITY · PI REHKOPF, DAVID H · NCI · award ends Apr 30, 2028 · The Upstream Center: Income Interventions to Address the Fundamental Causes of Cancer
NIH RePORTER · NIH RePORTER 11417139 (opens the source filing in a new tab)
- Grant
U54 · $386k · non-dilutive
Jun 26, 2023STANFORD UNIVERSITY · PI REHKOPF, DAVID H · NCI · award ends Apr 30, 2028 · Research and Methods Core
NIH RePORTER · NIH RePORTER 11417145 (opens the source filing in a new tab)
- Grant
R01 · $381k · non-dilutive
May 1, 2023UNIVERSITY OF CALIFORNIA AT DAVIS · PI FEJERMAN, LAURA · NCI · award ends Apr 30, 2028 · Her2 status of breast cancer in diverse populations: improving genetic prediction and understanding molecular correlates
NIH RePORTER · NIH RePORTER 11320872 (opens the source filing in a new tab)
- Grant
R01 · $58k · non-dilutive
May 1, 2023UNIVERSITY OF CALIFORNIA AT DAVIS · PI FEJERMAN, LAURA · NCI · award ends Apr 30, 2028 · Her2 status of breast cancer in diverse populations: improving genetic prediction and understanding molecular correlates
NIH RePORTER · NIH RePORTER 11512975 (opens the source filing in a new tab)
- Trial
NA registered
Dec 20, 2022Stress, Childhood Obesity · COMPLETED · sponsor: University of California, San Diego · Healing Experiences of Adversity Among Latinos (HEALthy4You)
ClinicalTrials.gov · NCT05676281 (opens the source filing in a new tab)
- Trial
NA registered
Oct 7, 2022Inactivity, Physical, Sedentary Behavior · COMPLETED · sponsor: University of California, San Diego · The YourMove Study: Optimizing Individualized and Adaptive mHealth Interventions Via Control Systems Engineering Methods
ClinicalTrials.gov · NCT05598996 (opens the source filing in a new tab)
- Grant
D43 · $310k · non-dilutive
Sep 1, 2022UNIVERSITY OF CALIFORNIA AT DAVIS · PI CARVAJAL CARMONA, LUIS GUILLERMO · NCI · award ends Aug 31, 2028 · UC Davis Multi-Disciplinary Cancer Research Training Program to Advance Precision Cancer Prevention and Care in Latin America.
NIH RePORTER · NIH RePORTER 11182563 (opens the source filing in a new tab)
- Trial
Study registered
Sep 1, 2020Multiple Myeloma · RECRUITING · sponsor: University of California, Davis · Development of a Research Infrastructure for Understanding and Addressing Multiple Myeloma Disparities
ClinicalTrials.gov · NCT04314752 (opens the source filing in a new tab)
Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources